New shot shows promise for severe Post-Baby depression in tiny study
NCT ID NCT02285504
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 26 times
Summary
This early study tested an experimental drug called SAGE-547 in 4 women with severe postpartum depression. The main goal was to see if the injection was safe and how the body processed it. Researchers also looked for signs that symptoms improved, but the study was too small to draw firm conclusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Chapel Hill, North Carolina, 27514, United States
Conditions
Explore the condition pages connected to this study.